Literature DB >> 23079812

Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.

Leilani Schwarcz1, Miao-Jung Chen, Eric Vittinghoff, Ling Hsu, Sandra Schwarcz.   

Abstract

OBJECTIVE: To measure the incidence and risk factors of AIDS-defining opportunistic illnesses (AOIs) in the pre-highly active antiretroviral therapy (HAART) (1993-1995), early-HAART (1996-2000), and late-HAART (2001-2008) periods.
DESIGN: Prospective cohort analysis of AIDS surveillance data.
METHODS: Individuals living with, or diagnosed with AIDS from 1993 through 2008 were included. Poisson regression models were used to estimate annual incidence rates of the eight most frequently occurring AOIs, and to compare these rates in the pre-HAART (1993-1995), early-HAART (1996-2000), and late-HAART (2001-2008) periods.
RESULTS: There were 18 733 individuals with AIDS included; 5788 were diagnosed prior to 1993 and 12 945 were diagnosed between 1 January 1993 and 31 December 2008. The incidence rates of Pneumocystis jiroveci pneumonia, wasting syndrome, Kaposi's sarcoma, HIV encephalopathy, cytomegalovirus retinitis, cytomegalovirus, and esophageal candidiasis decreased during the study period, with the largest declines observed between the pre-HAART and early-HAART periods. Incidence rates also decreased between the early-HAART and late-HAART periods, though not as sharply. Incidence rate reductions between the earliest and latest period ranged from 84 to 99%.
CONCLUSIONS: Steep declines in incidence of AOIs were found following the introduction of HAART and continued into the late-HAART era. These declines reflect the impact of HIV diagnosis and treatment on a population level.

Entities:  

Mesh:

Year:  2013        PMID: 23079812     DOI: 10.1097/QAD.0b013e32835b0fa2

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

1.  Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017.

Authors:  S Ickowicz; H Dong; L Ti; S Nolan; N Fairbairn; R Barrios; M-J Milloy
Journal:  AIDS Care       Date:  2020-05-31

2.  Older HIV-infected adults. Complex patients (III): Polypharmacy.

Authors:  Samuel F Freedman; Carrie Johnston; John J Faragon; Eugenia L Siegler; Tessa Del Carmen
Journal:  Eur Geriatr Med       Date:  2018-12-06       Impact factor: 1.710

3.  Opportunistic Infections and Mortality: Still Room for Improvement.

Authors:  Henry Masur; Sarah W Read
Journal:  J Infect Dis       Date:  2015-06-03       Impact factor: 5.226

Review 4.  The neuropathology of the adult cerebellum.

Authors:  Arnulf H Koeppen
Journal:  Handb Clin Neurol       Date:  2018

5.  Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Authors:  Cristiane C Lamas; Lara E Coelho; Beatriz J Grinsztejn; Valdilea G Veloso
Journal:  Infection       Date:  2017-06-28       Impact factor: 3.553

6.  AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.

Authors:  Viviane D Lima; Lillian Lourenço; Benita Yip; Robert S Hogg; Peter Phillips; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-03       Impact factor: 12.767

Review 7.  Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.

Authors:  David N Burns; Victor DeGruttola; Christopher D Pilcher; Mirjam Kretzschmar; Christopher M Gordon; Elizabeth H Flanagan; Christopher Duncombe; Myron S Cohen
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-11       Impact factor: 2.205

8.  Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

Authors:  Kate Buchacz; Bryan Lau; Yuezhou Jing; Ronald Bosch; Alison G Abraham; M John Gill; Michael J Silverberg; James J Goedert; Timothy R Sterling; Keri N Althoff; Jeffrey N Martin; Greer Burkholder; Neel Gandhi; Hasina Samji; Pragna Patel; Anita Rachlis; Jennifer E Thorne; Sonia Napravnik; Keith Henry; Angel Mayor; Kelly Gebo; Stephen J Gange; Richard D Moore; John T Brooks
Journal:  J Infect Dis       Date:  2016-04-18       Impact factor: 5.226

9.  Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare.

Authors:  Prattana Leenasirimakul; Yingna Liu; Choeng Jirawison; Nitta Khienprasit; Siripim Kamphaengkham; Somsanguan Ausayakhun; Jenny Chen; Michael Yen; David Heiden; Gary N Holland; Todd P Margolis; Jeremy D Keenan
Journal:  Br J Ophthalmol       Date:  2016-06-13       Impact factor: 4.638

Review 10.  Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.

Authors:  Meghan E Fitzpatrick; Ken M Kunisaki; Alison Morris
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.